Home/Blog/Canine Allergic Dermatitis and Atopy: NAVLE Study…
NAVLEDermatology·⏱ 10 min read·📅 Mar 28, 2026·by NAVLE Exam Prep Team·👁 0
Canine Allergic Dermatitis and Atopy: NAVLE Study Guide
Allergic skin disease is the most common reason dogs visit veterinarians, and it shows up reliably on the NAVLE. Three types dominate the question pool: canine atopic dermatitis (CAD), flea allergy dermatitis (FAD), and adverse food reaction. The exam almost always tests your ability to distinguish them by distribution, signalment, and seasonality – and then pick the right treatment.
Canine Atopic Dermatitis (CAD)
CAD is a Type I IgE-mediated hypersensitivity to environmental allergens – dust mites, pollens, mold spores. Allergen exposure triggers mast cell degranulation, histamine release, and the characteristic inflammatory cascade that keeps atopic dogs itchy year-round (or seasonally if pollens dominate).
Breed predisposition is a major NAVLE signal. West Highland White Terrier has one of the highest relative risks. Others to know: Golden Retriever, Labrador Retriever, Boxer, Bulldog, Shar Pei, and Cocker Spaniel. Age of onset is typically 1–3 years. If a dog develops pruritus before age 1 or after age 7, think harder about alternatives.
Distribution is the clinical anchor. CAD follows a ventral and flexural predilection: face (periocular, muzzle), pinnae, paws (interdigital, periungual), axillae, groin, and ventral abdomen. Chronic cases develop hyperpigmentation and lichenification – the thick, leathery "elephant skin" change that tells you this has been going on for months to years.
Secondary infections pile on constantly. Malassezia thrives in the warm, moist skin folds of atopic dogs and produces the classic yeasty smell, brown ceruminous otitis, and brown-stained toe jam from licking. Staphylococcus pseudintermedius causes pustules, epidermal collarettes, and honey-crusted erosions. Treating only the infection without addressing the underlying allergy produces an endless cycle of relapses.
Diagnosis uses the ICADA criteria (International Committee on Allergic Diseases of Animals) – a validated scoring system based on breed predisposition, age, distribution, and response to therapy. For allergen identification: intradermal skin testing is the gold standard; serum allergen-specific IgE testing is more accessible but has lower specificity.
Classic NAVLE Trap
Intradermal testing identifies allergens for immunotherapy formulation – it does NOT diagnose atopy. The diagnosis of CAD is clinical. Don't pick “intradermal testing” as the first step to confirm you're dealing with CAD.
Treatment Options for CAD
The NAVLE will ask you to match the drug to the mechanism or the clinical context:
Oclacitinib Apoquel — JAK1 inhibitor
→
Inhibits JAK1/JAK3 – blocks IL-31 signaling
→
Itch relief in <4 hours daily oral tablet
Lokivetmab Cytopoint — anti-IL-31 mAb
→
Monoclonal antibody neutralizes IL-31 directly
→
4–8 weeks duration monthly SQ injection
NAVLE Tip
Oclacitinib (Apoquel) works within 4 hours – use it when you need rapid itch control. Lokivetmab (Cytopoint) gives 4–8 weeks of relief from a single injection – ideal for owners who struggle with daily pills. Neither modifies underlying disease. Allergen-specific immunotherapy (ASIT) is the only treatment that alters the underlying immune response and is the recommended long-term disease-modifying option.
Flea Allergy Dermatitis (FAD)
FAD is the most common allergic skin disease in both dogs and cats. The reaction is to flea saliva, not the flea itself – so a single bite can trigger a severe reaction in a sensitized animal. You may never find a flea on the patient because allergic dogs groom them off aggressively.
Distribution is the diagnostic anchor for FAD: dorsal lumbosacral region, tailhead, and caudomedial thighs – the so-called "flea triangle." This is the opposite of atopy's ventral/facial distribution. Look for flea feces (black/brown specks on the skin that turn red-brown when moistened on a white paper towel – positive "flea dirt test" confirming digested blood).
Treatment is strict flea control on all pets in the household plus environmental treatment. Isoxazolines – fluralaner (Bravecto), sarolaner (Simparica), afoxolaner (NexGard) – are the current standard. Monthly flea prevention must be year-round in endemic areas.
Adverse Food Reaction (Food Allergy)
Adverse food reaction accounts for roughly 15–20% of allergic skin disease in dogs. Unlike atopy, it can occur at any age – even in dogs under 1 year or over 7 years. The pruritus is typically non-seasonal and year-round. Common culprit proteins: beef, dairy, chicken, wheat, lamb, soy. The allergy is to the protein, not preservatives or additives.
Concurrent GI signs (vomiting, diarrhea, increased frequency of defecation) appear in a meaningful subset of cases – their presence alongside pruritus should prompt food allergy higher on the differential list.
Diagnosis requires a strict hydrolyzed protein or novel protein elimination diet trial for 8–12 weeks. No treats, flavored medications, or table food during the trial – owner compliance is the biggest obstacle. Serum IgE food panels and intradermal testing are unreliable for food allergies and are not diagnostically valid. Confirmation is by provocation: reintroduce the original diet and watch for recurrence within 1–2 weeks.
NAVLE Pearl
Flea allergy = dorsolumbosacral / tailhead. Atopy = ventral / facial / paws. Food allergy = any age, non-seasonal, may have GI signs. The NAVLE signals the correct diagnosis through distribution and signalment before you reach the treatment options.
Classic NAVLE Trap
Food allergy occurs at any age and is non-seasonal. If you see a young puppy or an older dog with year-round pruritus – especially with GI signs – food allergy moves to the top. Don't default to atopy just because it's the most common. The exam will specifically construct signalments that don't fit the atopy age window to test this distinction.
Secondary Infections: Recognizing and Managing Them
The NAVLE often asks about secondary complications of allergic skin disease rather than the primary disease itself. Malassezia dermatitis shows cytology with peanut-shaped budding yeast ("footprint" or "snowman" cells on tape prep). Treatment: ketoconazole or itraconazole systemically; miconazole or chlorhexidine topically. Bacterial pyoderma from Staph shows cocci on cytology with neutrophils and macrophages. Surface pyoderma and superficial pyoderma respond to appropriate antibiotics guided by culture and sensitivity, and topical antiseptic therapy.
Topical therapy – antiseptic shampoos (chlorhexidine 2–4%), mousse, and wipes – is an important part of managing both secondary infections and barrier dysfunction in atopic dogs, and the NAVLE has tested this.
Want full NAVLE study guides and timed practice questions?
Premium subscribers get condition-by-condition study guides, species-filtered practice questions, timed exam simulations, and a week-by-week study roadmap built for the boards.
Test yourself before moving on. Click an answer to reveal the explanation.
Question 1
A 3-year-old West Highland White Terrier presents with year-round pruritus affecting the feet, axillae, and ventral abdomen. Physical examination reveals lichenification of the axillae and brown waxy discharge from the ear canals bilaterally. Tape cytology shows peanut-shaped budding organisms. Intradermal skin testing is performed and allergen-specific immunotherapy is formulated. What is the primary mechanism by which allergen-specific immunotherapy (ASIT) differs from oclacitinib for this patient?
Explanation
Allergen-specific immunotherapy (ASIT) is the only treatment for canine atopic dermatitis that alters the underlying immunological dysfunction rather than just controlling clinical signs. It works by inducing immune tolerance through mechanisms including upregulation of regulatory T-cells and class-switching from IgE to IgG4. ASIT achieves significant improvement or remission in 60-75% of patients. Option A describes oclacitinib (Apoquel), a JAK1 inhibitor. Option C describes lokivetmab (Cytopoint), an anti-IL-31 monoclonal antibody. Option D describes cyclosporine's mechanism. Option E is false -- ASIT takes months for full effect, while oclacitinib provides rapid relief within 4 hours.
Question 2
A 5-year-old mixed-breed dog presents with intense pruritus localized to the dorsal lumbosacral region, tailhead, and caudomedial thighs. The owner reports the dog chews its tailbase constantly. Physical examination reveals papules, crusts, and alopecia in this distribution. Black-brown specks are noted in the coat that turn reddish-brown when moistened on a white paper towel. Which treatment approach is MOST appropriate?
Explanation
The distribution (dorsal lumbosacral, tailhead, caudomedial thighs) and positive flea dirt test (black specks turning reddish-brown on moistened paper = digested blood = flea feces) confirm flea allergy dermatitis (FAD). FAD is a hypersensitivity to flea saliva -- a single bite triggers reactions in sensitized animals, so fleas may not be visible on the dog. Treatment requires strict flea control on ALL pets in the household plus environmental treatment. Isoxazolines (fluralaner/Bravecto, sarolaner/Simparica, afoxolaner/NexGard) are the current standard. Option A is for food allergy diagnosis. Option B is for atopy allergen identification. Options D and E control pruritus but do not eliminate the trigger.
Question 3
A 1.5-year-old Golden Retriever presents with a 4-month history of non-seasonal pruritus. The owner notes the dog has had loose stools and occasional vomiting alongside the skin signs. Pruritus affects the face, paws, and perianal region. The dog has been on the same commercial chicken-based diet since adoption. Which diagnostic test is MOST appropriate to evaluate the primary cause of this dog's pruritus?
Explanation
This signalment (young dog, any age) with non-seasonal pruritus AND concurrent GI signs (vomiting, loose stools) strongly suggests adverse food reaction. The concurrent GI signs are a key discriminating feature -- they are rare in atopy but common in food allergy. The ONLY valid diagnostic test for food allergy is a strict elimination diet trial using a hydrolyzed protein or novel protein diet for 8-12 weeks, with zero treats, table food, or flavored medications. Serum IgE food panels (Option A) and intradermal testing for foods (Option B) have poor sensitivity and specificity for food allergy and are not diagnostically valid. Skin biopsy (Option D) shows nonspecific inflammation. Chemistry/CBC (Option E) will not identify food allergy.
Question 4
A 4-year-old Labrador Retriever with confirmed canine atopic dermatitis presents for a recheck. The owner wants rapid itch relief starting today and prefers not to give daily medications long-term. Physical examination shows active pruritus with self-trauma. Which treatment BEST matches the owner's stated preferences?
Explanation
Lokivetmab (Cytopoint) is a caninized anti-IL-31 monoclonal antibody administered as a subcutaneous injection every 4-8 weeks. It directly neutralizes IL-31, a key cytokine in pruritus signaling in atopic dogs. A single injection provides 4-8 weeks of itch control without daily oral medications -- ideal for owners who prefer injection-based dosing intervals over daily pills. Onset of action is within 1 day. Option A (oclacitinib/Apoquel) works within 4 hours but requires daily oral dosing. Option C (ASIT) is the disease-modifying option but takes months for full effect. Option D (cyclosporine) requires daily dosing and 4-6 weeks to reach full effect. Option E (prednisone) is a short-term rescue option with significant side effects on long-term use.
Question 5
A 2-year-old Boxer with a 6-month history of pruritic skin disease is presented. Lesions include erythema and lichenification of the ventral abdomen, axillae, and interdigital spaces bilaterally. The pruritus is year-round with mild seasonal worsening in spring. Skin scrapings are negative. Cytology shows cocci with neutrophils. After treating the secondary infection, the dog improves only 30%. What is the MOST likely primary diagnosis and appropriate next step?
Explanation
Canine atopic dermatitis fits this presentation: Boxer (predisposed breed), age 1-3 years at onset, ventral/flexural/paw distribution, year-round pruritus with seasonal worsening, negative scrapings, and secondary bacterial infection that only partially explains the pruritus. The fact that treating the secondary infection yields only 30% improvement confirms a primary allergic disease is driving the cycle. Appropriate next steps are symptomatic control with oclacitinib (rapid onset, daily oral) or lokivetmab (monthly injection), treating secondary infections, and referral for intradermal testing and ASIT for long-term disease modification. Option A is for dorsolumbosacral/tailhead distribution. Option B (demodicosis) was excluded by negative scrapings. Option D (food trial) is reasonable to rule out concurrently but the breed, age, and distribution point to CAD. Option E (sarcoptic mange) causes non-seasonal intense pruritus but affects pinnae, elbows, and hocks.
Did this article help your studies?
Ready to Practice for the NAVLE?
Access 10,000+ exam-style questions with detailed explanations, topic breakdowns, and progress tracking.